Ongoing trend of pet ownership, growing awareness of animal health, technological innovations in veterinary medicine and diagnostics, and increased investment in research and development activities for animal drugs are factors anticipated to boost the veterinary CRO market.
Several pharmaceutical and biotechnology companies are increasingly outsourcing research to CROs in order to minimize costs and enhance efficiency, thereby further driving market growth. Additionally, heightened focus on zoonotic diseases and their impact on public health encourages more veterinary research initiatives.
According to the latest veterinary CRO market trends, the major companies are taking proactive initiatives to enhance research capabilities and develop innovative solutions, thereby reflecting a shift toward more specialized veterinary services.
In addition, globalization of the veterinary market is creating new opportunities with firms broadening their reach into emerging economies with focus on partnerships and knowledge sharing. This dynamic setup not only propels the evolution of animal health products but also facilitates compliance with evolving regulatory requirements, thus positioning veterinary CROs as essential strategic partners in the industry.
Veterinary Contract Research Organizations (CROs) play a significant role in research, development, and approval of veterinary products such as pharmaceuticals, vaccines, and medical devices. Veterinary CROs are experts in giving a vast array of services that help the research and development processes involved in getting new animal health products on the market. They include preclinical research, clinical trial management, regulatory affairs, and post-market surveillance.
Preclinical trials imply laboratory research and toxicology testing to understand how a product behaves with biological systems. After preclinical trials are conducted, veterinary CROs oversee clinical trials, which, in various phases, accrue data on the performance of the product among population of targeted animals.
Such experiments are planned meticulously to meet the regulatory requirements of organizations like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).
In addition to research and trial handling, veterinary CROs also extend regulatory affairs services to simplify the approval process on behalf of clients. Besides these essential services, veterinary CROs may further specialize in data management, statistical analysis, and consultancy services, with actionable insights being available for strategic decision-making to the clients.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Rising awareness above animal welfare is one of the key drivers to the veterinary CRO market. Numerous factors are responsible for this increased concern, such as more exposure to information, changes in consumer attitudes, and the ever-increasing importance that is being placed upon animal welfare within agriculture and household life.
As ownership of pets increases worldwide, owners of pets become more cognizant of their pet's health requirements and ailments they are prone to developing. Such an understanding prompts them to seek services of veterinarians in the form of routine check-ups, preventative medicine, and state-of-the-art medical care, thus placing heavy demands on veterinary services.
The emergence of social media and online platforms has also increased this awareness largely so that pet owners can share information, tips, and experience in the area of animal health. Pet owners are able to get valuable knowledge from the web forums and communities regarding diet, preventative care, and treatment from other pet owners who have gone through it before, thereby developing an active culture of health care management.
This trend also expands to livestock management, where the producers and farmers are better informed about the effects of animal health on productivity, profitability, and food safety. Greater focus on sustainable and moral farming practices has resulted in more questioning of animal husbandry procedures, where the farmers are hence looking for veterinary intervention that increases the health and welfare of their animals.
To address these trends, veterinary CROs are enhancing their capacity and offerings to meet the changing demands of the market. Additionally, there is growing focus on personalized medicine in animal clinics, where treatment is tailored according to the individual needs of animals based on genetic and environment determinants.
Veterinary medicine and diagnostics innovation ranks among the dominant growth drivers in the veterinary CRO market, and, in fact, transforms how animal health is researched and governed. Advanced use of technology has transformed much of veterinary medicine with better diagnostic functionality, more superior treatment procedures, and more effective research processes.
One of the greatest advances has been in diagnostic imaging, for instance, methods such as ultrasound, MRI, and CT scans. These let vets to obtained detailed knowledge on an animal's internal structure, facilitating early detection of diseases previously hard to diagnose.
In addition, advances in molecular diagnostics such as PCR-based technologies and next-generation sequencing have enabled veterinarians to detect pathogens and genetic disorders with unprecedented accuracy. It is particularly crucial when it comes to zoonotic and emerging public health diseases as it facilitates early detection and response to potential outbreaks.
Apart from diagnostic purposes, innovation in biotechnology in the form of production of biologics has transformed the treatment of animals. Biologics, namely monoclonal antibodies and vaccines, are gaining grounds to control all sorts of diseases, including cancer to infection disease.
Furthermore, telemedicine enables veterinarians to conduct remote consultations, monitor the health of patients, and provide follow-up treatment without direct consultation. Telemedicine not only enhances patient care but also leads pet owners to use the services of veterinarian’s sooner, thereby improving health.
The clinical trial services segment captures the veterinary CRO market, driven by stringent regulatory requirements that mandate thorough testing of the safety and efficacy of veterinary products.
Additionally, at the forefront of innovation is trial design, and veterinary CROs would greatly benefit from such innovation through successful delivery of essential animal health products through ethical consideration and regulatory frameworks.
The companion animals segment accounts for the largest size of the veterinary CRO market, fueled by a rise in pet ownership and growing consumer expenditures on pet health and wellness. Pet owners are increasingly interested in preventive care and sophisticated medical care, creating a high level of demand for studies of new products. The rising prevalence of chronic diseases in aging pets require continued clinical trials and product development for companion animals.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest veterinary CRO market report, North America dominated with the highest share in 2024. This can be attributed to the region's superior healthcare infrastructure and strong emphasis on research and development activities. The United States and Canada - both have numerous highly ranked pharmaceutical and biotechnology firms that closely collaborate with veterinary CROs to design and develop new animal health products.
Also, the pet-keeping culture in North America is increasingly being observed, and that is one of the key drivers to the veterinary CRO market. As families increasingly keep pets, preventive medicine, wellness schemes, and complex medical interventions are becoming increasingly popular. Pet owners are becoming increasingly aware of the healthcare needs of their pets.
Additionally, technological advancement offers the hub in setting the status of veterinary practice in North America. Wearable health technology, telemedicine, and new diagnostic techniques improve advanced veterinary medicine and offer avenues for better research. The technology is also being used by the CROs to enhance the gathering of data, support clinical trials, and enable remote consultation, all of which will enhance their activities.
Key players in the veterinary CRO industry are forming strategic collaborations to conduct targeted research initiatives. These partnerships play a crucial role in fostering innovation and driving market growth.
Charles River Laboratories, IDEXX Laboratories, Inc., BioAgile Therapeutics Private Limited, Royal GD, KLIFOVET GmbH, Argenta Holdco Limited, Cebiphar, Clinvet, STATKING Clinical Services, OCRvet, LÖHLEIN & WOLF VET RESEARCH, VETSPIN SRL, Inotiv, Knoell and Cloudbyz are some of the leading key players operating in the global market.
Each of these players have been have been profiled in the veterinary CRO market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 770.8 Mn |
| Forecast Value in 2035 | US$ 1.6 Bn |
| CAGR | 7.1% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Mn/Bn |
| Veterinary CRO Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global veterinary CRO market was valued at US$ 770.8 Mn in 2024.
The global veterinary CRO business is projected to reach more than US$ 1.6 Bn by the end of 2035.
Increasing pet ownership, growing awareness about animal health, and innovations in veterinary medicine and diagnostics.
The CAGR is anticipated to be 7.1% from 2025 to 2035.
Charles River Laboratories, IDEXX Laboratories, Inc., BioAgile Therapeutics Private Limited, Royal GD, KLIFOVET GmbH, Argenta Holdco Limited, Cebiphar, Clinvet, STATKING Clinical Services, OCRvet, LÖHLEIN & WOLF VET RESEARCH, VETSPIN SRL, Inotiv, Knoell, and Cloudbyz.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Veterinary CRO Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary CRO Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. List of Leading Veterinary CROs across Key Regions / Countries
5.2. Regulatory Scenario across Key Regions / Countries
5.3. PORTER’s Five Forces Analysis
5.4. PESTEL Analysis
5.5. Value Chain Analysis
5.6. Key Purchase Metrics for End-users
5.7. Go-to-Market Strategy for New Market Entrants
5.8. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
5.9. Benchmarking of the Services Offered by the Leading Competitors
6. Global Veterinary CRO Market Analysis and Forecasts, By Service Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Service Type, 2020-2035
6.3.1. Clinical Trial Services
6.3.2. Market Authorization and Regulatory Support
6.3.3. Toxicology Services
6.3.4. Pharmacokinetic Services
6.3.5. Laboratory Pathology Services
6.3.6. Others
6.4. Market Attractiveness By Service Type
7. Global Veterinary CRO Market Analysis and Forecasts, By Animal Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Animal Type, 2020-2035
7.3.1. Companion Animals
7.3.1.1. Dogs
7.3.1.2. Cats
7.3.1.3. Others
7.3.2. Livestock Animals
7.3.2.1. Cattle
7.3.2.2. Pigs
7.3.2.3. Sheep & Goat
7.3.2.4. Others
7.4. Market Attractiveness By Animal Type
8. Global Veterinary CRO Market Analysis and Forecasts, By Therapeutic Area
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Therapeutic Area, 2020-2035
8.3.1. Infectious Diseases
8.3.2. Orthopedic Disorders
8.3.3. Gastrointestinal Disorders
8.3.4. Dermatology
8.3.5. Oncology
8.3.6. Others
8.4. Market Attractiveness By Therapeutic Area
9. Global Veterinary CRO Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Veterinary CRO Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Service Type, 2020-2035
10.2.1. Clinical Trial Services
10.2.2. Market Authorization and Regulatory Support
10.2.3. Toxicology Services
10.2.4. Pharmacokinetic Services
10.2.5. Laboratory Pathology Services
10.2.6. Others
10.3. Market Value Forecast By Animal Type, 2020-2035
10.3.1. Companion Animals
10.3.1.1. Dogs
10.3.1.2. Cats
10.3.1.3. Others
10.3.2. Livestock Animals
10.3.2.1. Cattle
10.3.2.2. Pigs
10.3.2.3. Sheep & Goat
10.3.2.4. Others
10.4. Market Value Forecast By Therapeutic Area, 2020-2035
10.4.1. Infectious Diseases
10.4.2. Orthopedic Disorders
10.4.3. Gastrointestinal Disorders
10.4.4. Dermatology
10.4.5. Oncology
10.4.6. Others
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service Type
10.6.2. By Animal Type
10.6.3. By Therapeutic Area
10.6.4. By Country
11. Europe Veterinary CRO Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Service Type, 2020-2035
11.2.1. Clinical Trial Services
11.2.2. Market Authorization and Regulatory Support
11.2.3. Toxicology Services
11.2.4. Pharmacokinetic Services
11.2.5. Laboratory Pathology Services
11.2.6. Others
11.3. Market Value Forecast By Animal Type, 2020-2035
11.3.1. Companion Animals
11.3.1.1. Dogs
11.3.1.2. Cats
11.3.1.3. Others
11.3.2. Livestock Animals
11.3.2.1. Cattle
11.3.2.2. Pigs
11.3.2.3. Sheep & Goat
11.3.2.4. Others
11.4. Market Value Forecast By Therapeutic Area, 2020-2035
11.4.1. Infectious Diseases
11.4.2. Orthopedic Disorders
11.4.3. Gastrointestinal Disorders
11.4.4. Dermatology
11.4.5. Oncology
11.4.6. Others
11.5. Market Value Forecast By Country / Sub-region, 2020-2035
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By Animal Type
11.6.3. By Therapeutic Area
11.6.4. By Country / Sub-region
12. Asia Pacific Veterinary CRO Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Service Type, 2020-2035
12.2.1. Clinical Trial Services
12.2.2. Market Authorization and Regulatory Support
12.2.3. Toxicology Services
12.2.4. Pharmacokinetic Services
12.2.5. Laboratory Pathology Services
12.2.6. Others
12.3. Market Value Forecast By Animal Type, 2020-2035
12.3.1. Companion Animals
12.3.1.1. Dogs
12.3.1.2. Cats
12.3.1.3. Others
12.3.2. Livestock Animals
12.3.2.1. Cattle
12.3.2.2. Pigs
12.3.2.3. Sheep & Goat
12.3.2.4. Others
12.4. Market Value Forecast By Therapeutic Area, 2020-2035
12.4.1. Infectious Diseases
12.4.2. Orthopedic Disorders
12.4.3. Gastrointestinal Disorders
12.4.4. Dermatology
12.4.5. Oncology
12.4.6. Others
12.5. Market Value Forecast By Country / Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service Type
12.6.2. By Animal Type
12.6.3. By Therapeutic Area
12.6.4. By Country / Sub-region
13. Latin America Veterinary CRO Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Service Type, 2020-2035
13.2.1. Clinical Trial Services
13.2.2. Market Authorization and Regulatory Support
13.2.3. Toxicology Services
13.2.4. Pharmacokinetic Services
13.2.5. Laboratory Pathology Services
13.2.6. Others
13.3. Market Value Forecast By Animal Type, 2020-2035
13.3.1. Companion Animals
13.3.1.1. Dogs
13.3.1.2. Cats
13.3.1.3. Others
13.3.2. Livestock Animals
13.3.2.1. Cattle
13.3.2.2. Pigs
13.3.2.3. Sheep & Goat
13.3.2.4. Others
13.4. Market Value Forecast By Therapeutic Area, 2020-2035
13.4.1. Infectious Diseases
13.4.2. Orthopedic Disorders
13.4.3. Gastrointestinal Disorders
13.4.4. Dermatology
13.4.5. Oncology
13.4.6. Others
13.5. Market Value Forecast By Country / Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By Animal Type
13.6.3. By Therapeutic Area
13.6.4. By Country / Sub-region
14. Middle East & Africa Veterinary CRO Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Service Type, 2020-2035
14.2.1. Clinical Trial Services
14.2.2. Market Authorization and Regulatory Support
14.2.3. Toxicology Services
14.2.4. Pharmacokinetic Services
14.2.5. Laboratory Pathology Services
14.2.6. Others
14.3. Market Value Forecast By Animal Type, 2020-2035
14.3.1. Companion Animals
14.3.1.1. Dogs
14.3.1.2. Cats
14.3.1.3. Others
14.3.2. Livestock Animals
14.3.2.1. Cattle
14.3.2.2. Pigs
14.3.2.3. Sheep & Goat
14.3.2.4. Others
14.4. Market Value Forecast By Therapeutic Area, 2020-2035
14.4.1. Infectious Diseases
14.4.2. Orthopedic Disorders
14.4.3. Gastrointestinal Disorders
14.4.4. Dermatology
14.4.5. Oncology
14.4.6. Others
14.5. Market Value Forecast By Country / Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service Type
14.6.2. By Animal Type
14.6.3. By Therapeutic Area
14.6.4. By Country / Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2024)
15.3. Company Profiles
15.3.1. Charles River Laboratories
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. IDEXX Laboratories, Inc.
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. BioAgile Therapeutics Private Limited
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Royal GD
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. KLIFOVET GmbH
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Argenta Holdco Limited
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Cebiphar
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Clinvet
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. STATKING Clinical Services
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. OCRvet
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. LÖHLEIN & WOLF VET RESEARCH
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments
15.3.12. VETSPIN SRL
15.3.12.1. Company Overview
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Business Strategies
15.3.12.5. Recent Developments
15.3.13. Inotiv
15.3.13.1. Company Overview
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Business Strategies
15.3.13.5. Recent Developments
15.3.14. Knoell
15.3.14.1. Company Overview
15.3.14.2. Financial Overview
15.3.14.3. Product Portfolio
15.3.14.4. Business Strategies
15.3.14.5. Recent Developments
15.3.15. Cloudbyz
15.3.15.1. Company Overview
15.3.15.2. Financial Overview
15.3.15.3. Product Portfolio
15.3.15.4. Business Strategies
15.3.15.5. Recent Developments
List of Tables
Table 01: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 02: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 03: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 04: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 05: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
Table 06: Global Veterinary CRO Market Value (US$ Mn) Forecast, By Region, 2020-2035
Table 07: North America - Veterinary CRO Market Value (US$ Mn) Forecast, by Country, 2020-2035
Table 08: North America - Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 09: North America - Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 10: North America - Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 11: North America - Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 12: North America - Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
Table 13: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 15: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 16: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 17: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 18: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
Table 19: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 20: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 21: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 22: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 23: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 24: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
Table 25: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 26: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 27: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 28: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 29: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 30: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
Table 31: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 32: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, By Service Type, 2020-2035
Table 33: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, By Animal Type, 2020-2035
Table 34: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, By Companion Animals, 2020-2035
Table 35: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, By Livestock Animals, 2020-2035
Table 36: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020-2035
List of Figures
Figure 01: Global Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 02: Global Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 03: Global Veterinary CRO Market Revenue (US$ Mn), by Basic Clinical Trial Services, 2020-2035
Figure 04: Global Veterinary CRO Market Revenue (US$ Mn), by Market Authorization and Regulatory Support, 2020-2035
Figure 05: Global Veterinary CRO Market Revenue (US$ Mn), by Toxicology Services, 2020-2035
Figure 06: Global Veterinary CRO Market Revenue (US$ Mn), by Pharmacokinetic Services, 2020-2035
Figure 07: Global Veterinary CRO Market Revenue (US$ Mn), by Laboratory Pathology Services, 2020-2035
Figure 08: Global Veterinary CRO Market Revenue (US$ Mn), by Others, 2020-2035
Figure 09: Global Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 10: Global Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 11: Global Veterinary CRO Market Revenue (US$ Mn), by Companion Animals, 2020-2035
Figure 12: Global Veterinary CRO Market Revenue (US$ Mn), by Livestock Animals, 2020-2035
Figure 13: Global Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 14: Global Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Figure 15: Global Veterinary CRO Market Revenue (US$ Mn), by Infectious Diseases, 2020-2035
Figure 16: Global Veterinary CRO Market Revenue (US$ Mn), by Orthopedic Disorders, 2020-2035
Figure 17: Global Veterinary CRO Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2020-2035
Figure 18: Global Veterinary CRO Market Revenue (US$ Mn), by Dermatology, 2020-2035
Figure 19: Global Veterinary CRO Market Revenue (US$ Mn), by Oncology, 2020-2035
Figure 20: Global Veterinary CRO Market Revenue (US$ Mn), by Others, 2020-2035
Figure 21: Global Veterinary CRO Market Value Share Analysis, By Region, 2024 and 2035
Figure 22: Global Veterinary CRO Market Attractiveness Analysis, By Region, 2025-2035
Figure 23: North America - Veterinary CRO Market Value (US$ Mn) Forecast, 2020-2035
Figure 24: North America - Veterinary CRO Market Value Share Analysis, by Country, 2024 and 2035
Figure 25: North America - Veterinary CRO Market Attractiveness Analysis, by Country, 2025-2035
Figure 26: North America - Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 27: North America - Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 28: North America - Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 29: North America - Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 30: North America - Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 31: North America - Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Figure 32: Europe - Veterinary CRO Market Value (US$ Mn) Forecast, 2020-2035
Figure 33: Europe - Veterinary CRO Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 34: Europe - Veterinary CRO Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 35: Europe - Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 36: Europe - Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 37: Europe - Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 38: Europe - Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 39: Europe - Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 40: Europe - Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Figure 41: Asia Pacific - Veterinary CRO Market Value (US$ Mn) Forecast, 2020-2035
Figure 42: Asia Pacific - Veterinary CRO Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 43: Asia Pacific - Veterinary CRO Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 44: Asia Pacific - Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 45: Asia Pacific - Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 46: Asia Pacific - Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 47: Asia Pacific - Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 48: Asia Pacific - Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 49: Asia Pacific - Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Figure 50: Latin America - Veterinary CRO Market Value (US$ Mn) Forecast, 2020-2035
Figure 51: Latin America - Veterinary CRO Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 52: Latin America - Veterinary CRO Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 53: Latin America - Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 54: Latin America - Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 55: Latin America - Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 56: Latin America - Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 57: Latin America - Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 58: Latin America - Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Figure 59: Middle East & Africa - Veterinary CRO Market Value (US$ Mn) Forecast, 2020-2035
Figure 60: Middle East & Africa - Veterinary CRO Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 61: Middle East & Africa - Veterinary CRO Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 62: Middle East & Africa - Veterinary CRO Market Value Share Analysis, By Service Type, 2024 and 2035
Figure 63: Middle East & Africa - Veterinary CRO Market Attractiveness Analysis, By Service Type, 2025-2035
Figure 64: Middle East & Africa - Veterinary CRO Market Value Share Analysis, By Animal Type, 2024 and 2035
Figure 65: Middle East & Africa - Veterinary CRO Market Attractiveness Analysis, By Animal Type, 2025-2035
Figure 66: Middle East & Africa - Veterinary CRO Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 67: Middle East & Africa - Veterinary CRO Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Veterinary CRO Market
